Phthalylsulfathiazole
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.480 |
Chemical and physical data | |
Formula | C17H13N3O5S2 |
Molar mass | 403.43 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Phthalylsulfathiazole (also known as sulfathalidine) belongs to the group of drugs called sulfonamides. The drug is a broad-spectrum antimicrobial that can treat different types of infections including intestinal.[1] The mechanism of action depends on competitive antagonism with para-aminobenzoic acid and inhibition of dihydropteroate synthetase activity, which in turn leads to impaired synthesis of dihydrofolic acid and as a result its active metabolite necessary for the synthesis of purine and pyrimidine.
The drug is indicated in the treatment of dysentery, colitis, gastroenteritis and intestinal surgery. It is a derivative of sulfathiazole in which the phthalic acid substitution on the aniline nitrogen prevents it from being absorbed into the blood stream from the gut.[citation needed] Adverse effects may include allergic reactions, vitamin B insufficiency, agranulocytosis, and aplastic anemia.
References
- Articles with short description
- Short description matches Wikidata
- Articles with changed CASNo identifier
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All articles with unsourced statements
- Articles with unsourced statements from February 2023
- 2-Thiazolyl compounds
- Sulfonamide antibiotics
- All stub articles
- Gastrointestinal system drug stubs